Skip to main navigation Skip to search Skip to main content

Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

  • Robert H.I. Andtbacka
  • , Merrick Ross
  • , Igor Puzanov
  • , Mohammed Milhem
  • , Frances Collichio
  • , Keith A. Delman
  • , Thomas Amatruda
  • , Jonathan S. Zager
  • , Lee Cranmer
  • , Eddy Hsueh
  • , Lisa Chen
  • , Mark Shilkrut
  • , Howard L. Kaufman

Research output: Contribution to journal › Article › peer-review

281   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases

Biochemistry, Genetics and Molecular Biology